In this study, we investigate the role of constitutive non-canonical NF-κB activation in the myeloma epigenome and characterize the genomic landscape of NF-κB/p52 binding in MM cell lines that harbour genetic dysregulation of non-canonical NF-κB signalling. This evidence concerns the gene NFKB2 and Miyoshi myopathy.